BioMS Medical receives approval for key multiple sclerosis trial in Britain

EDMONTON (CP) - BioMS Medical Corp. said Friday it has received approval in Britain to expand a key trial for its treatment of multiple sclerosis. Trading in BioMS shares (TSX:MS) was halted pending the announcement....More